Tags |
|
|
Links |
|
|
Summary - Learning to Let Go
Letting go is never easy, and yet there are times when all you c
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ould do is to let go. Although the thought of letting go (be it
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
someone or something) brings panic and sadness, avoiding to thin
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
k about it is not helpful.
When you are in a bad relationship,
When you are in a bad relationship,
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
although you might not want to admit it, you will be able to sen
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
se that something is not right. Many people are confused or even
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
upset when their relationships don't go as planned. It is norma
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
l for people to hang onto their relationships for as long as the
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
y can, even if their hearts know that it is not right.
After tr
After tr
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ying to sort things out with no avail, the last thing and the on
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ly thing you can do for a bad relationship is to let go. To let
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
go is to accept that there is nothing else you could do to make
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
the relationship better, to understand that things don't always
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
happen as they are planned, to stop becoming obsessed, and to re
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
member that nobody is at fault. Life is always filled with optio
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ns and by letting go of the bad relationship, you now have new f
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
reedoms and opportunities. It's just a matter of time till you f
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ind the right person for yourself.
Nobody wants to say good-bye
Nobody wants to say good-bye
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
to the one they have loved, but there is a great comfort in kno
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
wing that some day, you will find someone to call your own again
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.summary.org.ua/article/200883/summary-Learning-to-Let-Go.html">Learning to Let Go</a>
BB link (for phorums):
[url=http://www.summary.org.ua/article/200883/summary-Learning-to-Let-Go.html]Learning to Let Go[/url]
Related Articles:
Semantic Search Engines - Forget the Way You Searched Before
5 Steps of Web Accessibility Testing
Bookmark it:
|